Structural insights into N-terminal IgV domain of BTNL2, a T cell inhibitory molecule, suggests a non-canonical binding interface for its putative receptors AJ Basak, S Maiti, A Hansda, D Mahata, K Duraivelan, SV Kundapura, ... Journal of molecular biology 432 (22), 5938-5950, 2020 | 15 | 2020 |
Peptide–MHC complexes: dressing up to manipulate T cells against autoimmunity and cancer A Sahoo, D Mukherjee, D Mahata, G Mukherjee Immunotherapy 14 (5), 337-350, 2022 | 1 | 2022 |
Targeting “Immunogenic Hotspots” in Dengue and Zika Virus: A Novel Approach to a Common Vaccine D Mahata, D Mukherjee, V Malviya, G Mukherjee bioRxiv, 2021.07. 23.453561, 2021 | 1 | 2021 |
Activation and differentiation of cognate T cells by a dextran‐based antigen‐presenting system for cancer immunotherapy D Mahata, D Mukherjee, D Biswas, S Basak, AJ Basak, I Jamir, N Pandey, ... European Journal of Immunology 53 (12), 2350528, 2023 | | 2023 |
Targeting ‘immunogenic hotspots’ in Dengue and Zika virus: an in silico approach to a common vaccine candidate D Mahata, D Mukherjee, K Duraivelan, V Malviya, P Parida, G Mukherjee Future Virology 18 (2), 87-106, 2023 | | 2023 |
Solution state structural and dynamic studies of mouse BTNL2, an orphan T cell coinhibitory molecule AJ Basak, S Maiti, A Hansda, D Mahata, W Lee, G Mukherjee, S De, ... PROTEIN SCIENCE 28, 152-152, 2019 | | 2019 |